Home > Boards > US Listed > Biotechs > DiaMedica Therapeutics Inc. (DMAC)

Secondary - 2.1M shares @ $4

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Plegee Member Profile
 
Followed By 2
Posts 113
Boards Moderated 0
Alias Born 08/17/06
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/23/2020 4:23:21 PM
DiaMedica Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference Business Wire - 11/19/2020 9:04:00 AM
DiaMedica Therapeutics to Participate in 11th Annual Craig-Hallum Alpha Select Conference Business Wire - 11/11/2020 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/10/2020 8:17:36 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/4/2020 4:33:36 PM
DiaMedica Provides a Business Update and Third Quarter 2020 Financial Results Business Wire - 11/4/2020 4:30:00 PM
DiaMedica Therapeutics to Report Third Quarter 2020 Financial Results and Provide a Business Update November 5, 2020 Business Wire - 10/28/2020 8:30:00 AM
DiaMedica Therapeutics to Present at Lake Street’s Virtual 4th Annual (BIG4) Conference September 17, 2020 Business Wire - 9/15/2020 8:15:00 AM
DiaMedica Announces First Patients Dosed in Diabetic Kidney Disease Cohort in Phase II REDUX CKD Clinical Study Business Wire - 9/14/2020 9:15:00 AM
DiaMedica Provides a Business Update and Second Quarter 2020 Financial Results Business Wire - 8/11/2020 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/11/2020 4:01:52 PM
DiaMedica Announces Closing of $23 Million Public Offering of Common Shares Business Wire - 8/10/2020 4:05:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/10/2020 6:17:19 AM
DiaMedica Therapeutics to Report Second Quarter 2020 Financials and Provide a Business Update August 12, 2020 Business Wire - 8/6/2020 4:05:00 PM
DiaMedica Announces Pricing of $20 Million Public Offering of Common Shares Business Wire - 8/6/2020 9:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2020 4:35:25 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/5/2020 4:32:02 PM
DiaMedica Announces Proposed Public Offering of Common Shares Business Wire - 8/5/2020 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2020 4:31:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/2/2020 5:37:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/2/2020 5:29:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/2/2020 5:20:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/2/2020 5:11:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/2/2020 5:00:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/2/2020 4:50:06 PM
Plegee   Tuesday, 02/11/20 04:55:20 PM
Re: None
Post # of 16 
Secondary - 2.1M shares @ $4

https://newsfilter.io/a/7daf655cf66c24a2f6fef7ce63b85019

Not a terrible first day for a new secondary issuance; stock recovered almost 50% from a 9% sell off in pre-market. I want to learn more about the quality/reputation of the acquirers. If the likes of Wainwright or other hatchet shops are involved, we all know how this will turn out. Prefer buying at support sub $4, but a temp floor may now be in. We'll see.

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences